Illumina appoints Everett Cunningham Chief Commercial Officer
ILMNIllumina(ILMN) Prnewswire·2024-06-03 19:11

Cunningham previously served as CCO for Exact Sciences and brings more than 20 years of commercial leadership across healthcare tech, life sciences, and pharma SAN DIEGO, June 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10.    Illumina, Inc., today announced the appointment of Everett Cunningham as Chief Commercial Officer, eff ...